Revolo Biotherapeutics Funding: $53M Raised, Series B (2021)
Revolo Biotherapeutics is based in New Orleans, LA. It has raised $53M in total funding. Latest round: Series B. Backed by Morningside.
Revolo Biotherapeutics funding overview
Revolo Biotherapeutics is based in New Orleans, LA. Revolo Biotherapeutics has raised $53M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in September 2021. The round record for Revolo Biotherapeutics runs through 2021; nothing later has been disclosed. Investors on record include Morningside.
Revolo Biotherapeutics at a glance
Total raised
$53M
Latest round
Series B
Latest round date
September 2021
Headquarters
New Orleans, LA
Notable investors
Morningside
Frequently asked about Revolo Biotherapeutics funding
How much has Revolo Biotherapeutics raised?
Revolo Biotherapeutics has raised $53M in total disclosed funding across the rounds on record.
Who has invested in Revolo Biotherapeutics?
Morningside are named among the investors backing Revolo Biotherapeutics.
What was the latest Revolo Biotherapeutics funding round?
The most recent disclosed round is a Series B, announced in September 2021.
Where is Revolo Biotherapeutics based?
Revolo Biotherapeutics is based in New Orleans, LA.
When did Revolo Biotherapeutics last raise?
The last disclosed Revolo Biotherapeutics round closed in September 2021 at Series B.
Totals shown for Revolo Biotherapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in New Orleans and the investors behind them below.
